Zimmer Biomet Holdings
Stock Forecast, Prediction & Price Target
Zimmer Biomet Holdings Financial Estimates
Zimmer Biomet Holdings Revenue Estimates
Zimmer Biomet Holdings EBITDA Estimates
Zimmer Biomet Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CHF6.82B N/A | CHF6.93B 1.64% | CHF7.39B 6.54% | Avg: CHF8.11B Low: CHF8.11B High: CHF8.11B avg. 9.79% | Avg: CHF8.45B Low: CHF8.45B High: CHF8.45B avg. 4.19% | Avg: CHF8.00B Low: CHF8.00B High: CHF8.00B avg. -5.35% | Avg: CHF8.31B Low: CHF8.31B High: CHF8.31B avg. 3.86% |
Net Income
% change YoY
| CHF401.6M N/A | CHF231.4M -42.38% | CHF1.02B 342.52% | Avg: CHF1.19B Low: CHF891.22M High: CHF1.40B avg. 17.04% | Avg: CHF1.34B Low: CHF1.25B High: CHF1.53B avg. 11.86% | Avg: CHF2.23B Low: CHF2.23B High: CHF2.23B avg. 66.43% | Avg: CHF2.34B Low: CHF2.34B High: CHF2.34B avg. 5.05% |
EBITDA
% change YoY
| CHF1.95B N/A | CHF1.99B 1.80% | CHF2.22B 11.53% | Avg: CHF2.32B Low: CHF2.32B High: CHF2.32B avg. 4.68% | Avg: CHF2.42B Low: CHF2.42B High: CHF2.42B avg. 4.19% | Avg: CHF2.29B Low: CHF2.29B High: CHF2.29B avg. -5.35% | Avg: CHF2.38B Low: CHF2.38B High: CHF2.38B avg. 3.86% |
EPS
% change YoY
| $1.93 N/A | $1.1 -43.00% | $4.88 343.63% | Avg: $5.66 Low: $4.25 High: $6.68 avg. 16.00% | Avg: $6.54 Low: $5.99 High: $7.32 avg. 15.55% | Avg: $10.64 Low: $10.64 High: $10.64 avg. 62.67% | Avg: $11.18 Low: $11.18 High: $11.18 avg. 5.05% |
Operating Expenses
% change YoY
| CHF3.86B N/A | CHF3.72B -3.44% | CHF4.03B 8.16% | Avg: CHF3.36B Low: CHF3.36B High: CHF3.36B avg. -16.67% | Avg: CHF3.50B Low: CHF3.50B High: CHF3.50B avg. 4.19% | Avg: CHF3.31B Low: CHF3.31B High: CHF3.31B avg. -5.35% | Avg: CHF3.44B Low: CHF3.44B High: CHF3.44B avg. 3.86% |
FAQ
What is Zimmer Biomet Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 25.09% in 2025-2028.
We have gathered data from 9 analysts. Their low estimate is 891.22M, average is 1.19B and high is 1.40B.
What is Zimmer Biomet Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 3.12% in 2025-2028.
We have gathered data from 27 analysts. Their low revenue estimate is CHF8.11B, average is CHF8.11B and high is CHF8.11B.
What is Zimmer Biomet Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 24.82% in 2025-2028.
We have gathered data from 9 analysts. Their low earnings per share estimate is $4.25, average is $5.66 and high is CHF6.68.